Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rimantadine pharmacokinetics after single and multiple doses.

R J Wills, D A Farolino, N Choma

    Antimicrobial Agents and Chemotherapy
    |May 1, 1987
    PubMed
    Summary

    This study on rimantadine found that its pharmacokinetics are linear. Drug accumulation during multiple doses is predictable, aiding in safe and effective dosing strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Recombinant adjuvant zoster vaccine-associated acute mucocutaneous toxicity.

    Scandinavian journal of rheumatology·2025
    Same author

    The percutaneous absorption of topically applied tretinoin and its effect on endogenous concentrations of tretinoin and its metabolites after single doses or long-term use.

    Journal of the American Academy of Dermatology·1997
    Same author

    A physiologically based pharmacokinetic model for retinoic acid and its metabolites.

    Journal of the American Academy of Dermatology·1997
    Same author

    Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam.

    Clinical pharmacology and therapeutics·1995
    Same author

    The role of pharmacokinetics in the development of biotechnologically derived agents.

    Clinical pharmacokinetics·1992
    Same author

    Quantitation of the enantiomers of rimantadine and its hydroxylated metabolites in human plasma by gas chromatography/mass spectrometry.

    Biomedical chromatography : BMC·1992

    Area of Science:

    • Pharmacology
    • Clinical Pharmacy
    • Drug Metabolism

    Background:

    • Rimantadine is an antiviral medication.
    • Understanding its pharmacokinetic profile is crucial for optimizing therapeutic use.
    • Previous studies have explored rimantadine's efficacy, but detailed pharmacokinetic data under varied dosing regimens require further elucidation.

    Purpose of the Study:

    • To investigate the pharmacokinetic properties of rimantadine in healthy adult males.
    • To compare two different multiple-dose regimens of rimantadine.
    • To determine the linearity and predictability of rimantadine accumulation.

    Main Methods:

    • A randomized study involving 24 healthy adult male volunteers.
    • Two distinct oral rimantadine regimens were administered.
    • Regimen 1: Single 100 mg dose, followed by 100 mg twice daily for 10 days.
    • Regimen 2: Single 100 mg dose, followed by 100 mg once daily for 10 days.

    Main Results:

    • The pharmacokinetic analysis indicated linear kinetics for rimantadine.
    • Drug accumulation during the multiple-dose phase was found to be predictable.
    • Both regimens were evaluated for their pharmacokinetic impact.

    Conclusions:

    • Rimantadine exhibits linear pharmacokinetics.
    • The accumulation of rimantadine with repeated dosing can be reliably predicted.
    • These findings support the development of evidence-based dosing guidelines for rimantadine.

    Related Experiment Videos